GFAP and depressive disorder: Mice in depression models such as chronic unpredictable mild stress (CUMS) showed decreased GFAP+ cell density, while riluzole reversed decreased GFPA mRNA expression and promoted astrocyte metabolism in CUMS mice (Banasr et al., 2010).